Avalon GloboCareALBT
About: Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Employees: 6
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
272% more capital invested
Capital invested by funds: $32K [Q1] → $119K (+$87.1K) [Q2]
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
30% more funds holding
Funds holding: 10 [Q1] → 13 (+3) [Q2]
1.38% more ownership
Funds ownership: 0.91% [Q1] → 2.29% (+1.38%) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for ALBT.